Trials / Completed
CompletedNCT00264303
CUTE (Chronic Urticaria Treatment Evaluation)
A Comparative Study on Clinical Efficacy and Safety of Levocetirizine 5 mg Oral Capsules Once Daily in the Morning vs. Desloratadine 5 mg Oral Capsules Once Daily in the Morning in Patients Suffering From Chronic Idiopathic Urticaria (CIU)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 886 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study to compare the clinical efficacy and safety of Levocetirizine vs. Desloratadine in patients suffering from Chronic Idiopathic Urticaria (CIU) measured by the mean pruritus severity score over the first week of treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levocetirizine | 5mg oral capsules, once daily, 4 week duration |
| DRUG | Desloratadine | 5mg oral capsules, once daily, 4 week duration |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2005-12-12
- Last updated
- 2011-08-31
- Results posted
- 2009-07-09
Locations
80 sites across 9 countries: Belgium, France, Germany, Italy, Malaysia, Romania, South Africa, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT00264303. Inclusion in this directory is not an endorsement.